MEB 12.5% 0.9¢ medibio limited

correct. for FDA approval a device or drug needs a study done in...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,579 Posts.
    lightbulb Created with Sketch. 52
    correct. for FDA approval a device or drug needs a study done in the US. for phase II that can be around $5m, phase I cheaper. Phase 3 5-8m depending on size etc.

    But unless they are planning an imminent trial and have the research contracts already done, the study protocols finalized and ethics submissions ready to be submitted, Im puzzled why they felt the need to offer a 50% discount while at the all time lows.

    Seems incompetent to me; unless there was pressure to get the insto's reset cheaply to average down which is more likely. Still shafts holders on their current holdings even tho there will be a rights issue in due course.

 
watchlist Created with Sketch. Add MEB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.